
About


Pathogen Access and Benefit-Sharing (P-ABS) under the draft WHO Pandemic Treaty: Why Many Vaccine, Therapeutic, and Diagnostic Companies will be in Scope
The EU member states’ votes banning a product cannot be presumed confidential: Why we litigated Case T-201/21 Covington & VanVooren vs European Commission (and won)
Historic Marine Biodiversity Treaty creates new Access and Benefit-Sharing obligations for life sciences companies

Historic Marine Biodiversity Treaty creates new Access and Benefit-Sharing obligations for life sciences companies

EU Pharma Legislation Review Series: GMO Medicines

EU Pharma Legislation Review Series: Addressing Environmental Risks
